Alternative CAR Therapies: Recent Approaches in Engineering Chimeric Antigen Receptor Immune Cells to Combat Cancer

For nearly three decades, chimeric antigen receptors (CARs) have captivated the interest of researchers seeking to find novel immunotherapies to treat cancer. CARs were first designed to work with T cells, and the first CAR T cell therapy was approved to treat B cell lymphoma in 2017. Recent advance...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno, Carlos, Haynie, Christopher, Cheever, Abigail, Weber, K. Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313317/
https://www.ncbi.nlm.nih.gov/pubmed/35884798
http://dx.doi.org/10.3390/biomedicines10071493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313317/
https://www.ncbi.nlm.nih.gov/pubmed/35884798
http://dx.doi.org/10.3390/biomedicines10071493

Ejemplares similares